Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|August 5, 1994
NMR solution structure of a peptide nucleic acid complexed with RNAS C Brown, S A Thomson, J M Veal, et al.
Clinical Biochemistry|December 31, 2022
Calcium requests in a primary care; An observational audit of biochemical requests and frequency of abnormal resultsA Sillars, R Livingstone, T M Yates, et al.
Calcified Tissue International|December 1, 1992
Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancyS J Gallacher, W D Fraser, F C Logue, et al.
Clinical Chemistry|March 1, 1993
Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related proteinW D Fraser, J Robinson, R Lawton, et al.
Bone and Mineral|December 1, 1991
A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemiaS J Gallacher, S H Ralston, W D Fraser, et al.
Bone and Mineral|February 1, 1991
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancyW D Fraser, F C Logue, S J Gallacher, et al.
Postgraduate Medical Journal|November 1, 1990
Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronateS J Gallacher, S H Ralston, F J Dryburgh, et al.
Clinical and Laboratory Haematology|May 3, 2000
Successful high dose therapy for relapsed mediastinal large B cell lymphoma following surgical repair of anterior chest wall defectF R MacLean, J P Hanley, W N Patton, et al.
European Journal of Endocrinology|October 1, 1994
Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancyS J Gallacher, W D Fraser, O J Owens, et al.
Thorax|November 1, 1992
Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot studyS J Gallacher, J A Fenner, K Anderson, et al.
Pageof 8